Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia.
Ignacio AlvarezMonica Diez-FairenMiquel AguilarJose Manuel GonzálezMontse YsamatJuan Pablo TartariMaria CarcelAlvaro AlonsoBritta BrixPhilipp ArendtPau PastorPublished in: European journal of neurology (2020)
These results suggest that emerging biomarkers in conjunction with core AD markers improve diagnosis of AD, are associated with the conversion from MCI into AD, and predict a faster progression of dementia.